Fair Value Measurements and Investments - Additional Information (Detail) - Neo Medical [Member] $ in Thousands, SFr in Millions				12 Months Ended
	Nov. 14, 2024 USD ($)	Nov. 14, 2024 CHF (SFr)	Oct. 01, 2020 USD ($)	Dec. 31, 2024 USD ($)	Oct. 01, 2020 CHF (SFr)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Convertible loans			$ 5,000		SFr 4.6
Sale of preferred equity securities	$ 7,400	SFr 6.6
Realized loss recognized in other expense, net	$ 5,800
Preferred Stock [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Amount of Preferred stock consideration			$ 5,000
Sale of preferred equity securities				$ (7,396)
Realized loss recognized in other expense, net				$ (5,779)